TIADYLT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Apr 2025)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86960965
- Registration number
- 5938286
- Mark type
- Stylized text
- Filed
- 01 Apr 2016
- Published for opposition
- 20 Sept 2016
- Registered
- 17 Dec 2019
- Attorney of record
- Anthony J. DiMarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hypertension, high blood pressure, angina, chest pain, some types of arrhythmia, and irregular heartbeats
Owner
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
Prosecution history
- 08 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Nov 2019 — USE AMENDMENT FILED
- 11 Nov 2019 — TEAS STATEMENT OF USE RECEIVED
- 11 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2019 — SOU EXTENSION 5 GRANTED
- 04 Apr 2019 — SOU EXTENSION 5 FILED
- 10 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL